Androgens act to stimulate spermatogenesis through androgen receptors (AR) on the Sertoli cells and peritubular myoid cells (PTM). Specific ablation of the AR in either cell type will cause a severe disruption of spermatogenesis. To determine whether androgens can stimulate spermatogenesis through direct action on the PTM alone or whether action 5 on the Sertoli cells is essential we have crossed hypogonadal (hpg) mice which lack gonadotrophins and intratesticular androgen with mice lacking androgen receptors (AR) either ubiquitously (ARKO) or specifically on the Sertoli cells (SCARKO). These hpg.ARKO and hpg.SCARKO mice were treated with testosterone (T) or dihydrotestosterone (DHT) for 7 days and testicular morphology and cell numbers 10 assessed. Androgen treatment did not affect Sertoli cell numbers in any animal group. Both T and DHT increased numbers of spermatogonia and spermatocytes in hpg mice but DHT has no effect on germ cell numbers in hpg.SCARKO and hpg.ARKO mice. T increased germ cell numbers in hpg.SCARKO and hpg.ARKO mice but this was associated with stimulation of FSH release. Results show that androgen stimulation of 15 spermatogenesis requires direct androgen action on the Sertoli cells.
Introduction
Spermatogenesis is regulated by follicle-stimulating hormone (FSH) and by androgen released from the Leydig cells in response to luteinising hormone (LH). In mice lacking 20 androgen receptors (AR) either through a natural mutation (Tfm) or through genomic manipulation (ARKO) there is severe disruption to spermatogenesis with a failure of germ cells to progress beyond the early stages of meiosis (1;2). In contrast, mice lacking FSH or the FSH-receptor are fertile, albeit with reduced germ cell number (3) (4) (5) (6) , indicating that FSH acts primarily to optimise spermatogenesis and germ cell number 25 while androgens are critical for the completion of meiosis and, therefore, fertility.
In the adult animal testicular ARs are expressed in Sertoli cells, Leydig cells and peritubular myoid cells (PTMs) (2) . The primary function of the Sertoli cells is to promote and maintain germ cell development through direct interaction with the cells and through generation of a unique microenvironment within the lumen of the seminiferous 30 tubules. In mice lacking ARs only in the Sertoli cells (SCARKO) spermatogenesis is largely blocked at meiosis (2;7;8) although the disruption to spermatogenesis in the SCARKO is less marked than in the Tfm or ARKO mouse. In addition to the SCARKO mouse, it has recently been reported that mice lacking ARs in the peritubular myoid cells (PTM-ARKO) show severe depletion of germ cell numbers and are infertile (9) . 35 This shows that androgen action through the PTMs is also essential for spermatogenesis and reveals a more complex interplay between endocrine stimulation, somatic cell activity and spermatogenesis than previously envisioned.
To examine these interactions more closely and to determine whether androgen can acutely stimulate spermatogenesis without a direct effect on the Sertoli cell we have 40 generated mice lacking gonadotrophins and Sertoli cell androgen receptors by crossing SCARKO mice with hypogonadal (hpg) mice. The hpg mouse lacks circulating gonadotrophins (10) with a consequent loss of androgen production (11) and disruption to spermatogenesis (10). Treatment of hpg.SCARKO mice with androgen will directly stimulate all androgen-sensitive testicular cells apart from the Sertoli cell and show 45 whether direct androgen action on the Sertoli cells is essential for germ cell development.
Materials and Methods

Animals and treatments
All mice were bred and all procedures carried out under UK Home Office Licence and 50
with the approval of a local ethical review committee. SCARKO and ARKO mice have been previously generated by crossing female mice carrying an Ar with a floxed exon 2 (Ar fl ) with male mice expressing Cre under the regulation of the Sertoli cell specific promoter Amh or the ubiquitous promoter Pgk-1 (2;12). The hpg.SCARKO and hpg.ARKO mice were generated as previously described (6;13). 55 Adult mice (10 weeks) were treated with androgen by subcutaneous implantation of a 2cm silastic capsule containing testosterone (T) or the non-aromatisable androgen dihydrotestosterone (DHT). Margaret? Mice were killed one week after the start of treatment and testes snap frozen in liquid nitrogen or fixed overnight. Fixation was either in 4% paraformaldehyde/1% gluteraldehyde in phosphate buffer (0.1M, pH 7.4) for 60 preparation of semi-thin sections or in Bouin's for subsequent morphometric analysis or immunohistochemistry.
Hormone measurement
Serum levels of FSH were measured by ELISA (IDS, Bolden, UK). 65
Histology, stereology and immunohistochemistry
To prepare semi-thin (1μm) sections testes were embedded in araldite and sections stained with toluidine blue. For stereological analysis, testes were embedded in Technovit 7100 resin, cut into sections (20μm), and stained with Harris' hematoxylin. The total 70 testis volume was estimated using the Cavalieri principle (14) . The optical disector technique (15) was used to count the number of Sertoli cells and germ cells in each testis.
Each cell type was identified by previously described criteria (16;17) . The numerical density of each cell type was estimated using an Olympus BX50 microscope fitted with a motorized stage (Prior Scientific Instruments, Cambridge, UK) and Stereologer software 75 (Systems Planning Analysis, Alexandria, VA, USA). Control data for this study includes data from a previous study (6) plus additional animals.
For immunohistochemistry, testes were embedded in paraffin and sections (5 µm) were mounted on glass slides, dewaxed, and rehydrated. Sections were incubated with rabbit anti-AR antiserum (sc-816, Santa Cruz Biotechnology) following heat-induced 80 antigen retrieval (2) . Bound primary antibody was detected using a peroxidaseconjugated secondary antibody, followed by a fluorescyl-tyramide amplification step with visualization using 3,3-diaminobenzidine tetrahydrochloride (Dako UK Ltd, Cambridgeshire). For negative control samples, nonimmune serum replaced primary antiserum.
Statistical analysis
Data were analysed using two factor analysis of variance (anova) with hormone treatment and animal group as the two variables. To show whether differences between individual groups were significant t-tests were employed using the pooled variance from the anova. 90
Data were log transformed where appropriate to avoid heterogeneity of variance. Data on FSH levels were analysed by the non-parametric Kruskal-Wallis test followed by the MannWhitney test.
Results 95
Androgen receptor expression
Immunohistochemistry was used to localise ARs in the testes of hpg, hpg.SCARKO and hpg.ARKO mice (Fig 1) . In the hpg testis ARs were clearly present in the PTMs and interstitial tissue with lighter staining apparent in the Sertoli cells ( Fig 1A) . In hpg.SCARKO mice there was clear staining for ARs in the PTMs and interstitial tissue 100 while no specific staining was seen in the hpg.ARKO mice (Fig 1B & C) . For comparison, testes from normal mice were included and AR expression was apparent in Sertoli cells, PTMs and interstitial tissue (Fig 1D) .
Effect of androgen on testis size, testis morphology and SV weight 105
Hypogonadal mice are cryptorchid due to lack of post-natal androgen production.
Prolonged androgen-treatment of these animal will induce testicular descent but the duration of treatment in the experiments described here was insufficient to affect testicular localisation. Treatment of hpg and hpg.SCARKO mice with T or DHT did, however, increase testicular volume with the effect on hpg mice being more marked (Fig2) . Surprisingly, T also increased the volume of hpg.ARKO mice but there was no effect of DHT (Fig 2) .
Treatment of hpg mice with T or DHT caused an increase in seminiferous tubule diameter (Figs 2 & 3) , clear establishment of a tubular lumen and an apparent increase in germ cell number (Fig 3) . In some tubules spermatogenesis 115 progressed to the round spermatid stage following treatment with T (Fig 3) . Testosterone also increased tubule diameter in hpg.SCARKO and hpg.ARKO mice but DHT only had an effect in hpg.SCARKO mice (Fig 2 & 3) .
Seminal vesicle weights were significantly increased by T and DHT in both hpg and hpg.SCARKO mice (Fig 2) . Due to a lack of ARs seminal vesicles do not develop in 120
hpg.ARKO mice.
Stereology
Sertoli cell number was unaffected by androgen treatment in any animal group (Fig 4) .
Total germ cell number was increased by T in all three animal groups (Fig 5) . In contrast, 125
DHT increased total germ cell number in hpg mice but had no effect on hpg.SCARKO or hpg.ARKO mice (Fig 5) . Similarly, T and DHT both increased spermatogonial and spermatocyte numbers in hpg mice but only T was effective in hpg.SCARKO and hpg.ARKO mice. Formation of round spermatids was limited mainly to hpg mice treated with T (Fig 5) . A very small number of round spermatids were formed in hpg mice 130 treated with DHT and hpg.SCARKO mice treated with T (Fig 5) .
FSH levels
Serum FSH levels in hpg and hpg.ARKO mice were all below 1.5 ng/ml and in hpg.SCARKO mice all levels were below the level of detection of the assay (0.2ng/ml) 135 (Fig 6) . For comparison, serum FSH levels in normal adult male mice are about 25ng/ml (18) . Treatment of hpg, hpg.SCARKO and hpg.ARKO mice with T caused a significant increase in serum FSH but DHT had no clear effect (Fig 6) . therefore, that a recent study has reported major disruption to spermatogenesis in mice lacking AR in the PTMs (9) . Total loss of germ cells in these animals was greater than in SCARKO mice and appeared to be largely through disruption of the premeiotic cells (9) .
The results are all the more surprising since Cre expression (and, therefore, AR ablation) 155 occurred in less than 50% of PTMs. It is now clear, therefore, that androgens act to promote spermatogenesis through actions on both Sertoli cells and PTMs. To study this dual control in more detail we have used animal models based on the hpg mouse which lacks germ cell development and which is highly sensitive to androgen action (25;26). By combining hpg mice with SCARKO mice we have been able to determine whether 160 androgens can stimulate spermatogenesis without direct effects through AR in the Sertoli cell. Results show that (non-aromatisable) androgen action through the PTMs (and Leydig cells) alone is insufficient to stimulate spermatogenesis in these animals and that direct androgen action on the Sertoli cells is essential.
The requirement for direct androgen action on the Sertoli cell to stimulate 165 spermatogenesis may appear to be obvious from the phenotype of the SCARKO mouse (2). The major defect in this animal, however, is loss of post-meiotic cells and this does not rule out additional direct spermatogenic effects of androgen through other cell types.
In particular, pre-meiotic germ cell numbers are not markedly affected in the SCARKO mouse (spermatogonial numbers are normal and spermatocyte numbers are about 50-60% 170 of normal (2;27)) indicating that androgen action through other cells combined with FSH action on the Sertoli cells is sufficient to maintain reasonable pre-meiotic germ cell numbers. The phenotype of the FSHRKO and PTM-ARKO mice and the effects of FSH on the hpg would also be consistent with this hypothesis (3;6;9). In data reported here, however, the failure of DHT to stimulate tubule and germ cell development in the 175 hpg.SCARKO mouse, in comparison to the hpg mouse, shows that androgen stimulation of spermatogonial and spermatocyte development requires direct action on the Sertoli cells. These experiments do not rule out the possibility that androgen action through the PTMs is also essential to stimulate spermatogenesis and studies using hpg.PTM-ARKO mice would clarify this. In addition, longer-term direct effects of androgen through the 180 PTMs, without direct effects on the Sertoli cells, cannot be excluded. The 7-day timecourse was chosen for studies reported here because longer periods of androgen treatment will induce testicular descent in hpg and hpg.SCARKO mice which, in itself, will affect germ cell development.
A previous study has reported that T and DHT have similar effects on the 185 development of spermatogenesis in the hpg mouse over an 8-week time period (25). Our results largely confirm this report although DHT was less effective than T for the induction of round spermatid formation which may be due to the relatively short duration of the current study with attendant lack of testicular descent. Unexpectedly, however, we observed marked differences in the effects of T and DHT on spermatogenesis in 190 hpg.SCARKO and hpg.ARKO mice. These differences appear to be due to the induction of FSH release from the pituitary by T but not DHT. In normal adult males androgens act to decrease circulating FSH primarily through effects on hypothalamic GnRH. In the hpg mouse, however, the primary effect of exogenous steroids is likely to be at the pituitary and there is evidence from in vivo and in vitro studies that T can stimulate pituitary FSH 195 and Fshb levels (28-31). More pertinently, so far as this study is concerned, it has also been shown that oestrogen will increase circulating FSH levels in male hpg mice (32;33). 
